As symptoms such as a depressed mood, anxiety, irritability, low stress tolerance, and full depressive syndrome are often reported in patients with hyperprolactinaemia, and the normalization of PRL and treatment with bromocriptine reduces depressive symptoms [41], it would seem important to test the level of this hormone before starting pharmacotherapy for depression. The gene discussed is PRL; the disease is depressive disorder.